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Summary.-Papain-solubilized tumour-specific antigens from the aminoazo dye-
induced rat hepatoma D23 were purified by a combination of lectin affinity and
immunoadsorbent column chromatography. Isolated antigens were radio-iodinated
using three procedures and analysed for their reaction with specific antibodies in
syngeneic immune sera by double-antibody co-precipitation tests and by the rebind-
ing of labelled antigens to specific and non-relevant antibodies immobilized on
Sepharose-4B. Soluble hepatoma D23-specific antigens were labile to radiolabelling,
and for optimal retention of serological reactivity it was necessary to protect the
antigenic determinant by performing the chloramine T method of iodination with
antigen bound to the immunoadsorbent followed by elution from the solid phase with
3M NaSCN. Immunoadsorption chromatography indicated that one consequence of
radiolabelling hepatoma D23-specific antigen with 1'5I was a reduction in the affinity
of the labelled antigen for its syngeneic specific antibody.
AMINOAZO DYE-INDUCED rat hepatomas
are characterized by the expression of
individually distinct tumour-specific anti-
gens demonstrable serologically or by
tumour transplant rejection (Baldwin,
1973; Moore, 1978). The serologically
defined tumour-specific antigen associated
with the rat hepatoma D23 is expressed on
an integral plasma-membrane glycopro-
tein, and the antigenically active, water-
soluble glycopeptide released by limited
proteolysis with papain displays a molecu-
lar weight of 55,000 (Price & Baldwin,
1977). There is currently a need to develop
objective assays for the detection of these
antigens, so that the chemical analysis of
these products may be conducted on a
more quantitative basis. Radio-isotopic
antiglobulin tests have revealed tumour-
specific antigens on rat hepatomas by the
detection of specific antibodies in syn-
geneic immune sera binding to surface-
membrane antigens on dispersed tumour
cells (Al-Sheikly et al., 1979). Although
antibody binding was demonstrable at
serum dilutions as low as 1/250, these
reactions are not sufficiently strong to
allow modification of the test as a routine
assay for acellular antigens by determining
their capacity to inhibit antibody-binding
reactions.
The present study was therefore under-
taken to establish the appropriate condi-
tions for radiolabelling lectin affinity and
immunoadsorbent-purified, papain-solubil-
ized hepatoma-associated antigens with
the retention of serological activity, so
that cell-free radioimunoassays might be
developed for the routine quantitation of
these components.
MATERIALS AND METHODS
Rats, tumours and sera
Inbred WAB/Not (Nottingham Cancer
Research Campaign subline of WAB) rats
were maintained by single-line brother-sister
mating. Hepatomas D23 andD192,inducedby
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oral administration of 4-dimethylaminoazo-
benzene, sarcoma Mc7, induced by s.c.
injection of 3-methyl-cholanthrene, and the
spontaneously arising mammary carcinoma
Sp4, were maintained by serial s.c. passage
in WAB/Not rats. Hepatoma D23- and D192-
immune serum, sarcoma Mc7-immune serum
and mammary carcinoma Sp4-immune serum
w%Nere prepared in syngeneic rats by weekly
i.p. injections of 2 x 107 y-irradiated (15,000
R) tumour cells. Serum donors were bled by
cardiac puncture under ether anaesthesia, and
the serum pools were collected and stored at
-20°C. For the isolation of hepatoma D23
antigen, cells from the ascitic variant of D23
were injected i.p. in y-irradiated (450 R)
WAB/Not rats to prevent the coating of
tumour cells by IgG antibody (Robins, 1975).
Solubilization and purification of hepatoma
D23 specific antigen
Hepatoma D23 ascites cells were harvested
from the peritoneal cavity of tumour donors
and the cells washed x 3 by centrifugation
with Hanks's balanced salt solution (HBSS).
Papain (18 mg) (Sigma Chemical Co., King-
ston upon Thames) was added to 1P8 x 1010
viable tumour cells suspended at 1.08/ml in
HBSS containing 5mM L-cysteine, and hydro-
lysis was allowed to proceed for 45 min at
37°C. The cell suspension was rapidly cooled
on ice, the cells were sedimented by centri-
fugation at 400 g for 15 min and the super-
natant was centrifuged at 105,000 g for 60
min to ensure solubility. Papain was removed
by ion-exchange chromatography on DEAE-
cellulose, as previously described by Baldwin
et al. (1973a). The soluble extract was then
subjected to a series of chromatographic
procedures as summarized in Table I. Briefly,
the antigenic glycopeptide fraction bound to
Concanavalin A-linked Sepharose-4B (Phar-
macia Ltd., Uppsala, Sweden) was eluted
with 0-2M o-methylmannoside according to
the manufacturer's recommendations. This
fraction was passed over a column of immo-
bilized Ig from a sheep anti-rat IgG antiserum
linked to CNBr-activated Sepharose 4B
(Pharmacia Ltd.) and the unbound fraction
was applied to a column of Sepharose-4B-
conjugated IgG from syngeneic WAB/Not
anti-hepatoma D23 immune serum. (All
immunoadsorbents were prepared by conju-
gating protein to CNBr-activated Sepharose-
4B at 10 mg protein/g dry weight ofactivated
Sepharose, and >90% of protein was regu-
larly conjugated to the solid phase). After
washing the column with phosphate-buffered
saline, pH 7-3, (PBS) to remove non-bound
material, the column was washed with 0dIM
glycine-NaOH, 0-05M NaCl (pH 9.0) to
eliminate non-specifically bound material
(Zoller & Matzku, 1976). Hepatoma D23
antigen was dissociated from the immuno-
adsorbent by application of 3M NaSCN, and
the eluate was desalted by passage over
Sephadex-G25 (Pharmacia Ltd.) equilibrated
with PBS. The full details ofthese preparative
procedures have been given elsewhere (Bald-
win et al., 1973a, b; Preston & Price, 1977;
Bowen & Baldwin, 1979; Price et al., 1979)
and such antigen preparations were character-
ized both by the specific inhibition ofindirect
membrane immunofluoreseence reactions and
by their capacity to induce tumour-specific
antibody in treated rats.
Radioiodination of hepatoma D23 antigens
The following procedures were used in an
attempt to prepare radiolabelled hepatoma
D23-specific antigens retaining serological
reactivity with antibodies in syngeneic WAB/
Not antihepatoma D23 immune serum. All
iodinations were performed on the same batch
of purified antigens.
Direct labelling of soluble antigens.-A
modified chloramine T method (McConahey &
Dixon, 1966) was adopted to label 10 jg
aliquots of protein with 1251 (Na 1251, Radio-
chemical Centre, Amersham, Bucks.) and
reaction conditions were varied to give specific
activities in the range 041-15 /XCi/lg protein,
protein concentrations being determined by
the Lowry method. At the highest level of
labelling used, the calculated number of
iodine atoms per molecule of antigen did not
exceed unity.
Conjugation of 125I-labelled tyrosine to
soluble antigens.-Tyrosine (Tyr) (100 ng) was
labelled with 500 ,uCi 1251 by a modification
of the lactoperoxidase-catalysed reaction
described by Phillips & Morrison (1971). The
reaction was performed in 0-05M sodium caco-
dylate buffer (pH 5-6) using 5 ng lactoperoxi-
dase (Sigma Chemical Co.) and a total of
600ng H202 wasaddedto thereactionmixture
(55 ,ul) over a period of 28 min. The 1251-
labelled Tyr was coupled to 5 jug of immuno-
adsorbent-purified hepatoma D23 antigen
by the formation of amide bonds with 10 ,ug
EDC (1-ethyl-3(3-dimethylamino-propyl)-
carbodiimide-hydrochloride, Sigma Chemical
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Co.). Coupling was allowed to proceed at pH
5 6 in a total reaction volume of 85 pi at 4°C
for 18 h. The 1251-Tyr coupled hepatoma D23
antigen was separated from free 1251 and
unreacted 1251-Tyr by chromatography on
Sephadex-G150 equilibrated with PBS con-
taiming 0-050% bovine serum albumin (BSA.
Sigma Chemical Co.). The specific activity
of the labelled antigen was 20 [Ci/yug
protein, about 90%O of radioactivity being
precipitable by 10% trichloracetic acid
(TCA).
Indirect labelling of soluble antigen immo-
bilized on an affinity substrate. Briefly,
immunoadsorbent-purified hepatoma D23
antigen (, 10 Htg protein) was incubated with
Sepharose-4B-linked IgG from WAB/Not
anti-D23 immune serum (0-1 ml of 5000
suspension). The pellet was washed and
reacted with Na 1251 (500 jtCi) using the
reactants described by McConahey & Dixon
(1966). Elution of radiolabelled antigen wras
performed with 3M Na SCN after washing the
pellet with 0dIM glycine-NaOH, 0-5M NaCl
(pH 9.0). Radio-labelled hepatoma D23
antigen was chromatographed on Sephadex-
G25 equilibrated in PBS containing 0 050o
BSA to effect buffer exchange and 85+3%
(6 determinations) of radioactivity was pre-
cipitable with 1000 TCA.
Co-precipitation radioimmnunoassay
Polystyrene round-bottomed tubes (9.5 x
63-5 mm) were pre-coated with 10% foetal
calf serum (FCS) in PBS. Radiolabelled
antigen preparations were dispensed in 10ulO
aliquots (0.7-1-8 ng protein/tube) and incu-
bated with 20 of WAB/Not anti-hepatoma
D23 immune serum, other immune serum or
normal WAB/Not serum for 18 h at 4°C. The
precipitating antiglobulin reagent (sheep
anti-rat IgG or goat anti-rat IgG) was added
at a dilution previously established to pre-
cipitate 100% rat IgG by standard quantita-
tive precipitation tests using 1251-labelled
WAB/Not IgG. The reactants were incubated
at room temperature for 90 min and 10 ml
PBS containing 0-05 BSA was added to
each tube before centrifugation at 1000 g for
10 min. Supernatants were discarded and
pellets were washed with PBS-BSA x3
centrifugation at 1000 g for 10 min before
determining their content of radioactivity
with an LKB-Wallac Gamma Counter.
Results were recorded in terms of co-
precipitation of 1251-labelled hepatoma D23
antigen, where Qo co-precipitation
(ct/min in precipitate-
ct/min in medium control 100
-(ct/min precipitable with 10% TCA_ x
ct/min in medium control
Rebinding of 1251-labelled soluble antigen
to immunoadsorbents. Radio-iodinated anti-
gens (100 1l at 5-10 pg/ml) were applied to
columns (, 2 ml volume) of Sepharose-4B-
linked IgG from hepatoma D23 or D192-
immune serum. These columns were washed
and eluted with the same buffers and dis-
sociating agent as described for the prepara-
tion ofantigen by specific immunoadsorption,
and the distribution of radioactivity in un-
bound fractions and 3M NaSCN-eluted frac-
tions was determined.
RESULTS
The chloramine T method ofMcConahey
& Dixon (1966) for the trace iodination of
proteins was efficient at radiolabelling
papain-solubilized hepatoma D23 antigen
purified by lectin affinity and immuno-
adsorbent column chromatography accord-
TABLE I. Chromatographic purification of
hepatoma D23-specific antigen
Papain solubtliz(Itioni of surfaice-membralne
glycoproteinis
1-8 x 101'lhepatoma D23 ascites cells treate(l with
18-0 mg papain, '37C, 45 min and soluble extract
collected
Removal of papaein
Ion-exchange clhromatography on DEAE cellulose;
membrane glycoproteins eluted with 05OM NaCl in
Tris-phosphate (pH 4.5)
Lectin affinity chromaitography
Material bound to Sepharose-4Bl-inked Con A an(1
eluted with 0-2M a methylmannosidle
Affinity-subtractiont chromatography
Non-bound material collected from Seplharose-4B-
linked sheep anti-rat IgG
Specific affinity chromatography
Material applied to Sepharose-4B-linked syngeneic
anti-liepatoma D23 TgG. Non-specifically bouncd
material removed with pH 9 0 buffer. Antigen elute(l
withi 3M NaSCN
Hepatoma D23-specific antigen2
( 20 Zg protein)
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ing to the procedure in Table I. About
40% ofadded 1251 was regularly recovered
in labelled antigen preparations when the
reaction conditions were varied to achieve
specific activities between 01 and 15
HCi/pg protein. The results ofassaying one
of these preparations (sp. act. 5 IuCi4/g)
in co-precipitation tests with syngeneic
rat sera (hepatoma D23-immune serum,
sarcoma Mc7-immune serum and normal
rat serum) and the heterologous anti-
globulin reagent are summarized in Exp. 1,
Table II, and it is evident that although
there was preferential precipitation using
WAB/Not anti-D23 serum (75.0 + 9.70/)
the non-specific precipitation by normal
WAB/Not serum or WAB/Not anti-Mc7
serum was unacceptably high (51.5 + 4-3
and 66-3 + 4.0% respectively). Comparable
levels of precipitation were also achieved
using antigen preparations labelled with
specific activities over the full range tested
of 0-1 to 15 uCi/pg protein. Clearly,
denaturation and aggregation of the anti-
genic preparation and/or chemical damage
to the antigenic determinant may have
accounted for these findings, and alterna-
tive radiolabelling procedures were
adopted in order to minimize these prob-
lems.
By introducing 1251 into hepatoma D23
antigen by coupling 1251-tyrosine (1251I
Tyr) to protein witlh the bifunctional
reagent I-ethyl-3(3-dimethylaminopro-
pyl)-carbodiimide, it was attempted to
avoid possible chemical inactivation of
antigen following oxidation of tyrosine
with chloramine T. In co-precipitation
tests, 39-6 + 8`9% of 1251-Tyr-coupled
D23 antigen was precipitated using WAB/
Not anti-D23 serum, compared with
10-7 + 2.0% with normal WAB/Not serum
(P< 0.01) and Il0 + 0.7%/ with WAB/Not
anti-Mc7 serum (P< 0.005; Exp. 2,
Table II).
Next, it was attempted to protect the
antigenic determinant during radio-
iodination by reacting immunoadsorbent-
bound antigen with Na 1251, using a
modified chloramine T procedure. After
removal of 125I by washing, the radio-
labelled antigen was dissociated from the
solid phase with 3M NaSCN, and this
material (referred to as "indirect 125I
labelled" D23 antigen) was analysed in
the co-precipitation test. In Table II, the
results of 3 separate assays using this type
of antigen are presented in Exps 3-5. In
each experiment, the precipitation of
antigen with WAB/Not anti-D23 serum
TABLE II.-Co-precipitation of 125I-labelled tumour antigens
Exp.
No. Antigen*
1 Direct 1251-labelled D23 antigen
2 125I-Tyrosine-coupled D23 antigen
3 Inidirect 1251-labclled D23 antigen
4 Indirect 1251-labelled D23 antigen
5 Indirect 1251-labelled D23 antigen
% Coprecipitated by WAB/Not serum (mean +s.d.)t
Anti-D23 Anti-D192 Anti-Mc7 Normal serum
NS < 0 05t
75 0+9-7 N.D.§ 66-3+4 0 51-5+4-3
<0 05
- <0.005 NS
39-6+8-9 N.D. 10 0+0 7 10-7+2-0
<0-01
< <005 NS
44-8+11-6 12 9+5-2 N.D. 6-4+4 2
<0-01 I
172+84
NS - NS
8-3+5-6 N.D.
I- <005 1 i-
56-4 + 18-7 16-4 + 6-1
< 0 05
< 0 05
- NS
N.D.
-1 0 + 5 9
17-4 + 6-5
I-
* Prepared as in Materials and Methods.
t Results ofeach experiment are expressed as mean of 3 determinationis.
I Probabilities (P) calculated by Student's t test.
§ Not done.
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TABLE III.-Radioimiunoadsorbent chromcatography of 1251-labelled tumour antigens
Antigen
Direct 1251-labelledt D23 antigen
1251-Tyrosine-coupled D2:3 antigen
Indirect 1251-labelled D23 antigen
Indlirect 1251-labellel D 192A antigen5
Indlireet 1251-labelled Sp4 antigen16
0°, Bounl/eluted (mean +s.d.)
Anti-1)23' n Anti-D1922n
50+2-5 3 50+ 30 3
200+ 10-3 3 6-4 l
325+57 4 5-8 1
5-5 1 14-8 1
2-6 1 6-7 l
I Sepiharose-4B-linked WrAB/Not ainti-1)23 IgG.
2 Sepharose-4B-linked WVAB/Not aniti-DI)92 IgG.
3 % increase in bindiing of 1251-labelle(d antigen to its appropriate immuinoadsorbent.
4 Ratio of binding to specific immunioadsorbent to bin(ling to irrelevant immunoa(dsorbent.
5D1)192A 3sr extract was incubatedl wvith Sepharose-4B-linked W\TAB/Not anti-D192A IgG. After appro-
priate w!ashing, the Seplharose pellet was labelled withl 25J as 1escribe( in the text.
6 Partially ptirifiedl Sp4 antigens were prepared by papain hydrolysis ofextra-nuclear membranes (Baldwin
et al., 1973b) clhromatographly on Con A-Sceplarose and immunoadsorption on Sepharose-linked WAB/Not
anti-Sp4 IgG. Specifically eltitedl antigen from this adsorbent, was re-applie(d to an identical immuno-
a(lsorbent andl ra(diolabelled by the inidirect metlhod as (lescribe(l in the text.
n = Number of cliromatogi-aplie separations.
was significantly higher than that ob-
tained using normal WAB/Not serum, and
in Experiments 3 and 5 the increased pre-
cipitation with anti-D23 serum was
statistically significantly greater than that
determined using an irrelevant syngeneic
immune serum (WAB/Not anti-DJ 92
serum).
The results of these co-precipitation
tests indicate that preferential reactivity
of labelled D23 antigen with D23-immune
serum compared with normal rat serum or
an irrelevant immune serum, may be
demonstrated, although non-specific inter-
actions with rat sera may lead to high
background precipitation (e.g. Exp. 1,
Table II). The three types of radio-
labelled antigen preparation were, there-
fore, assayed for their capacity to rebind
to hepatoma D23 immune serum IgG
coupled to Sepharose-4B beads. Using this
procedure, nonspecific adsorption could
be reduced by washing the immuno-
adsorbent with 0 1M glycine-NaOH, 0-51sI
NaC1 buffer (pH 9.0) (Zoller & Matzku,
1976) and possible decreases in the affinity
of labelled antigen for syngeneic anti-
bodies following the secondary reaction
with a precipitating antiglobulin reagent
could be avoided. A total of 19 immuno-
adsorbent columns were prepared, and the
results in Table III demonstrate that
hepatoma D23 antigen directly radio-
iodinated by the chloramine T method
failed to rebind to Sepharose-4B-immobil-
ized WAB/Not anti-D23 serum IgG, and
also did not bind to immobilized IgG from
an irrelevant syngeneic immune serum
(WAB/Not anti-D192 serum) indicating
substantial if not total loss of antigenic
activity. Hepatoma D23 antigen labelled
with 1251-Tyr reacted preferentially with
immobilized antibody from WAB/Not
anti-D23 serum, 20 0% being retained in
the solid phase, compared with only 6.4%
bound to an irrelevant syngeneic immune
serum IgG (Table III). 3255% ofindirectly
labelled D23 antigen was retained upon
the relevant immunoadsorbent, compared
with only 5o8% bound to the irrelevant
anti-DI92 immunoadsorbent, giving a
specific binding ratio of 5 6 (Table III).
The specificity of these interactions was
further analysed using antigen prepara-
tions isolated from the rat hepatoma Dl92
and rat mammary carcinoma Sp4 using
the same procedure as for hepatoma D23
antigen (Table I). Elevated binding of
indirect 1251-labelled D192 antigen was
detected (148%o binding to D182-immune
IgGC compared with 5.5%o binding to D23-
immune IgG) and the 1251-labelled Sp4
antigen failed to bind to either immuno-
adsorbent (Table III).
One interpretation of these findings is
that radiolabelling of purified, papain-
solubilized hepatoma D23 antigen modi-
fies its reactivity with tumour-immune
0O Specific
binding3
0
13-6
26-7
9.3
Specific
ratio4
1-0
3-1
5-6
2-6
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COLUMIN A
|O IM glycine NaOH + 0.5M NaCI
pH990 3M NaSCN
I
10 20 30 40 50 60
FRACTION NUMBER (25 drops)
FIGURE. Radioimmunoadsorbent chromato-
graphy of 1251-Tyr-coupled hepatoma D23
antigen on Sepharose-4B-linked WAB/Not
anti-D23 IgG. Column A dimensions =
26 x 50 mm, column B dimensions = 450 x
9 mm. The sample applied to Column B
was the unbouindt fraction recovered from
Column A.
serum, by reducing its affinity for syn-
geneic antibodies. This is supported by
the radioimmunoadsorbent chromato-
graphy experiments shown in the Figure.
When 1251-Tyr-coupled hepatoma D23
was applied to a conventional immuno-
adsorbent column of Sepharose 4B-linked
WAB/Not anti-D23 IgG (26 mm in length
x 50 mm in diameter, Column A) most of
the labelled protein passed through the
column as a single peak. However, if the
affinity substrate was packed into a long,
narrow column (450 mm in length x 9 mm
in diameter, Column B) the unbound
fraction was found to contain a proportion
of antigen which was retarded by inter-
action with immobilized antibody. This
effect was not found using an irrelevant
immunoadsorbent (Sepharose-4B-conju-
gated WAB/Not anti-DI 92 serum IgG)
and was not chromatographic, as distinct
from ani immunoaffinity, phenomenon,
since labelled antigen eluted from primary
amine-linked Sepharose-4B as a single
peak. These findings further confirm the
proposal that radiolabelled hepatoma D23
antigen exhibits a reduced affinity for
syngeneic antibodies, since unlabelled
antigens have been found to be retained
on their appropriate immunoadsorbent,
and dissociating conditions are required to
effect their release.
DISCUSSION
Many attempts have now been made to
purify tumour-specific antigens from what
are initially highly heterogeneous extracts,
the eventual aim of these studies being to
obtain a chemical definition of the speci-
ficity ofthese determinants. At the present
time the major problem limiting progress
in this area is the lack of sensitive and
quantitative immunoassays for soluble
tumour-specific antigens. However, the
early work of Thomson et al. (1973) using
a solid-phase radioimmunoassay for anti-
gen in the serum of rats bearing grafts of
a 3-methylcholanthrene-induced sarcoma
suggests that it is possible to develop cell-
free immunoassays of the required sensi-
tivity, though in more recent studies
Thomson et al. (1976) have returned to
indirect membrane-immunofluoresence
tests to monitor the purification of
sarcoma-associated antigens.
As an alternative, co-precipitation tests
may provide a worthwhile approach for
the quantitation of soluble tumour anti-
gens. This procedure has already been used
by Wolf et al. (1976) for the estimation of
circulating antigen in mice bearing the
SL2 lymphoma, but as the authors pointed
out, the assay could only be regarded as
semi-quantitative because of the rela-
tively high backgrounds and interference
with normal serum constituents.
Using the 3-methylcholanthrene-in-
duced murine sarcoma, Meth A, Natori
et al. (1978) have largely eliminated non-
specific immunoprecipitation of labelled
antigen by pre-absorbing the anti-serum
721722 D. HANNANT, J. G. BOWEN. M. R. PRICE AND R. W. BALDWIN
in vivo. It should be emphasized however
that the antiserum used was a hetero-
logous serum prepared against a partially
purified Meth A antigen fraction, and so
determinants other than those recognized
by syngeneic imnmune sera may be de-
tected. An additional complication arises
since other studies have established that
although syngeneic anti-Meth A sera are
specifically cytotoxic for Meth A cells
(DeLeo et al., 1977) syngeneic antisera are
also reactive in radioimmunoprecipitation
tests with a common, transformation-
related antigen in chemically induced
sarcomas and other transformed cell lines
(DeLeo et al., 1979). This information is
in itself of interest in defining the trans-
formation process, though from the present
investigation it would appear that this
transformation-related protein, p53, is
not being detected in the rat hepatoma
model, since the labelled antigens retain
individually distinct specificity in their
reaction with syngeneic antibody. Thus, a
major conclusion from the results in this
report is that serological reactivity may be
retained in radioiodinated antigen pre-
parations, though care must be taken in
choosing the method of radiolabelling. In
particular, the mild oxidizing agent chlor-
amine T would appear to be particularly
deleterious to these antigens, which might
imply that tyrosine is a component of, or
a residue in the immediate environment of,
the antigenic determinant itself. The loss
of affinity of radiolabelled hepatoma D23
antigen for appropriate specific antibodies
is reflected in the radioimmunoadsorption
chromatography experiments shown in
the Figure. Although immunoadsorption
chromatography on insolubilized anti-
bodies of very low affinity has been
established as an effective procedure for
the large-scale isolation of tumour-asso-
ciated antigens (Ruoslahti, 1978) this
particular result has other significance in
terms of the development of a cell-free
radioimmunoassay, since the affinity con-
stant for the binding of unlabelled, in-
hibitor antigen will be higher than that
for its radiolabelled counterpart. This
would then indicate that, for a cell-free
radioimmunoassay for hepatoma D23 anti-
gen, it may be more appropriate to use
metabolically radiolabelled antigens, or
alternatively an unlabelled reference
soluble antigen must be used in conjunc-
tion with a secondary radioactive indi-
cator. Both approaches are currently
being explored and, for the latter, efforts
are being directed towards the develop-
ment of an assay with which the specific
binding of purified hepatoma D23-specific
antigen to immobilized antibody is re-
vealed by the uptake of 1251-labelled
Concanavalin A to the glycosylated moiety
of the antigenic glycopeptide.
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